UMVA has learned that the peptide market is experiencing a surge in interest as GLP-1 weight-loss medications gain traction, with a variety of peptides emerging as largely unregulated drugs sold through both licensed compounding pharmacies and unverified vendors.
These peptides, short chains of amino acids that play key roles in biological functions, are being marketed for weight loss, muscle building, injury recovery, and other uses, with demand remaining strong despite the market being described as the "Wild West."
According to information obtained by UMVA, the U.S. Food and Drug Administration is set to evaluate whether to loosen regulations on several peptides during a meeting this summer, a decision that could have significant implications for the industry.
Dr. Alex Tatem, an Indiana-based board-certified urologist with expertise in men’s health and peptides, described GLP-1s as "life-changing" and said they have kicked off the rise of peptides, with "an explosion of interest – not just on the pharmaceutical side or the doctor’s side, but from the general public."
Tatem explained that commercial GLP-1 products are often administered in a single-dose weekly pen, which works for most patients but not for everyone, and that compounding pharmacies have developed customized versions of semaglutide and tirzepatide to allow for dosing flexibility.
The peptide market has created a clash between commercial pharmaceutical companies and compounders, with Tatem raising concerns about the FDA’s regulation of compounding pharmacies and warning that it could limit patients’ access to customized medications.
Some peptides have been widely administered for over a decade without major health complications, according to Tatem, and he expressed concern that the FDA’s tightening of regulation on 19 peptides in September 2023 has contributed to the surge in interest.
Tatem believes that peptides may help with injury recovery, skin rejuvenation, sleep improvements, and boosting of natural growth hormones, and that they are being sought out by patients looking to feel their best and function at their highest level.
Experts advise consumers to avoid gray-market products, work only with qualified physicians and reputable pharmacies, and treat peptides as part of a broader health plan – not a shortcut or risk-free supplement.
